AXIM BIOTECHNOLOGIES, INC. (AXIM) › Operating Cash FlowAXIM BIOTECHNOLOGIES, INC. (AXIM) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: $4.0K2013: -$33.0K2014: -$339.0K2015: -$1.54M2016: -$1.29M2019: -$5.04M2020: -$3.22M2021: -$2.49M2022: -$2.04M2023: -$1.03M-$1.03M2011Operating Cash Flow (USD)2023Fiscal YearOperating Cash FlowChange YoY2023-$1.03M+49.6%2022-$2.04M+17.8%2021-$2.49M+22.7%2020-$3.22M+36.2%2019-$5.04M—2016-$1.29M+15.9%2015-$1.54M-354.0%2014-$339.0K-926.7%2013-$33.0K—2011$4.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share